NCPA endorses reintroduction of Senate FTC/PBM billsNCPA issued gratitude to Sens. Cantwell and Grassley for their efforts to "pull back the curtain on PBMs and push for FTC review of anticompetitive PBM practices." Bausch + Lomb kicks off social media campaign for AMD awarenessThe campaign features personal stories and images from Bausch + Lomb SightMatters community members during age-related macular degeneration month. Aurobindo receives FDA nod for generic Pennsaid Diclofenac sodium topical solution is indicated for the treatment of osteoarthritis. CVS Health to acquire Oak Street Health for $10.6B CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, which represents an enterprise value of approximately $10.6 billion. Cutter’s Poison Ivy Scrub makes its debut Cutter’s Poison Ivy Scrub helps remove irritating plant oils found in poison ivy, poison oak and poison sumac, the company said. FDA halts emergency use of Evusheld Data show Evusheld is unlikely to be active against certain SARS-CoV-2 variants, the FDA said. Alvotech, Advanz Pharma enter commercialization agreement for Xolair biosimilar Omalizumab is used to treat patients with allergic asthma, chronic spontaneous urticaria and nasal polyps. TheracosBio receives FDA OK for Brenzavvy Brenzavvy is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes. Bajaj Medical debuts 2 generics Generic oral rinse (O.12% CHG) and generic lactulose solution 10g/15ml are being introduced into the marketplace. BeiGene receives FDA OK for Brukinsa Brukinsa (zanubrutinib) is used for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. First Previous 111 112 113 114 115 Next Last
